Hematopoietic Stem Cell Stocks List

Recent Signals

Date Stock Signal Type
2021-02-25 BLCM 20 DMA Resistance Bearish
2021-02-25 CBLI Calm After Storm Range Contraction
2021-02-25 CMRX Pocket Pivot Bullish Swing Setup
2021-02-25 CO Volume Surge Other
2021-02-25 CO Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-25 CO Pocket Pivot Bullish Swing Setup
2021-02-25 FATE Expansion Pivot Sell Setup Bearish Swing Setup
2021-02-25 FATE 20 DMA Resistance Bearish
2021-02-25 FATE 50 DMA Resistance Bearish
2021-02-25 FATE Stochastic Reached Oversold Weakness
2021-02-25 FATE MACD Bearish Centerline Cross Bearish
2021-02-25 HGEN Fell Below 50 DMA Bearish
2021-02-25 HGEN Stochastic Reached Oversold Weakness
2021-02-25 HGEN 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-25 NTLA 20 DMA Resistance Bearish
2021-02-25 NTLA 50 DMA Resistance Bearish
2021-02-25 NTLA Expansion Pivot Sell Setup Bearish Swing Setup
2021-02-25 PRTC Fell Below 20 DMA Bearish

Recent News for Hematopoietic Stem Cell Stocks

Date Stock Title
Feb 26 FATE Fate Therapeutics initiated buy at BofA despite early-stage pipeline
Feb 26 FATE Premarket analyst action - healthcare
Feb 26 CMRX Chimerix' (CMRX) CEO Mike Sherman on Q4 2020 Results - Earnings Call Transcript
Feb 26 CMRX Chimerix (CMRX) Q4 2020 Earnings Call Transcript
Feb 26 CBLI INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER
Feb 26 NTLA Intellia Therapeutics, Inc. (NTLA) Q4 2020 Earnings Call Transcript
Feb 25 NTLA Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q4 2020 Results - Earnings Call Transcript
Feb 25 PRTC PureTech Announces Publication of Glyph™ Platform Preclinical Proof-of-Concept Study in Journal of Controlled Release
Feb 25 CMRX Chimerix's DSTAT Shows Promising Results In First Cohort Of COVID-19 Study
Feb 25 CMRX The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Feb 25 FIXX Homology Medicines to Participate in Upcoming Investor and Patient Advocacy Conferences
Feb 25 NTLA Intellia Therapeutics EPS misses by $0.09, misses on revenue
Feb 25 NTLA Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results
Feb 25 HGEN Humanigen to Present at Multiple Investor Conferences in March
Feb 25 CMRX Chimerix EPS beats by $0.01, misses on revenue
Feb 25 CMRX Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update
Feb 25 CMRX Chimerix Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT
Feb 25 CMRX Chimerix, Inc. to Host Earnings Call
Feb 25 CO Global Cord Blood Corp. to Host Earnings Call
Feb 25 FATE Fate Therapeutics Inc (FATE) Q4 2020 Earnings Call Transcript
Related Industries: Biotechnology